Over 10 years of research and development at Bascom Palmer Eye Institute, ranked #1 in the US for ophthalmology.
Bascom Palmer is ranked the number one eye hospital in the U.S., and where our AI diagnostics and vision augmentation platform is continuously developed.
Our technology is the culmination of over 10 years of clinical and scientific research and development. This effort is led by Heru’s Founder and CEO Mohamed Abou Shousha, MD, PhD, associate professor of clinical ophthalmology, Bascom Palmer Eye Institute.
After years of feeling limited by options to help improve his patients’ lives, Dr. Abou Shousha became inspired and he and his team of leading physicians, scientists, and engineers set out to develop Heru’s artificial intelligence (AI) powered wearable device.
The rapid introduction of telemedicine, and the rising prevalence of glaucoma worldwide, illustrates the need for a portable and user-friendly platform that offers a novel and more cost-effective means of testing.
Founder, President, and CEO
Mohamed Abou Shousha, MD, PhD is Heru’s President and Chief Executive Officer. Dr. Abou Shousha is a practicing ophthalmologist at the University of Miami’s Bascom Palmer Eye Institute, where he serves as Associate Professor of Clinical Ophthalmology, Electrical and Computer Engineering, and Biomedical Engineering.
He and his team of clinicians and engineers spent over ten years conducting clinical and scientific research of ophthalmic imaging and artificial intelligence (AI) algorithms that led to Heru AI powered wearable device. His work has been published in leading peer reviewed ophthalmology journals. In addition to other prestigious awards, Dr. Abou Shousha was awarded multi-million dollars R01 and K23 awards from the National Eye Institute, the Stanley J. Glaser Award, the American Academy of Ophthalmology Achievement Award, Achievement Award of the Association of University Professor of Ophthalmology (AUPO) and the 6 Best Paper of Session award of the American Society of Cataract and Refractive Surgery (ASCRS).
Chairman of the Board
Fred Drasner is Chairman of Three Seasons Capital, LLC, a venture capital firm. Mr. Drasner, with a partner, acquired U. S. News &World Report and served as its CEO and Co-Chairman from 1985 to 2004. In 1993, they acquired the New York Daily News and he remained co-owner, Chief Executive Officer and Co-Publisher until 2004. Mr. Drasner founded Fast Company Magazine in 1995 and served as CEO until its sale 1999. In 1985, he started Applied Graphics Technologies, took it public in 1996 (NASDAQ), and served as its Chairman and CEO from 1985 until its sale in 2003. During that period, it grew into the world’s largest Digital Image Management Company
He was an initial investor in Snyder Communications (NYSE) and a board member until its sale to Havas for $2.3 billion in 1999. He was co-owner and Vice Chairman of The Washington Redskins football team from 1999 to 2004. Mr. Drasner was the founder of the Vehicle Production Group in 2007 and served as its chairman until its sale in 2013.
Board Member
Chris Dewey is a founding investor and board member of many successful startups, including MAKO Surgical Corp, which is now part of Stryker, Auris Surgical Corp, which is now part of Johnson & Johnson, ShockWave Medical, which went public in 2019, Cephea Valve Technologies, which is now part of Abbot Labs, Insightec, and Magic Leap. He holds an MBA from the Wharton School of Business.
Board Member
Kerri-Lynn is the former Chief Technology Officer for Healthcare and Life Sciences for Microsoft Industry Solutions. She serves as an advisor in the Mixed Reality and connected IoT space and is passionate about AR/VR/MR and IoT’s potential to healthcare. Kerri-Lynn also previously held an executive role at Kaiser Permanente focused on driving the success of transformational programs.
Board Member
Richard K. Parrish II, MD is a world-renown glaucoma specialist and is the Edward W.D. Norton Chair in Ophthalmology and Associate Dean for Graduate Medical Education to the University of Miami Miller School of Medicine. He also serves as Chairman of the Graduate Medical Education Committee and is the designated institutional representative for the Jackson Health System/Jackson Memorial Hospital.
Board Member
Rajesh Rajpal, MD is the Founder of See Clearly Vision, a group practice in the Washington, D.C. Area. He previously served as Chief Medical Officer for Avedro (acquired by Glaukos) and is Chief Medical Officer and Global Head of Clinical and Medical Affairs at Johnson & Johnson Vision.
Board Member
Ron Williams is the current Chairman and CEO of RW2 Enterprises, and former Chairman and CEO of Aetna Inc. During his tenure, Aetna was named FORTUNE’s most admired company in the Health Care Insurance and Managed Care category for three consecutive years. He served as both Chairman and CEO of Aetna from 2006 to 2010, and as Chairman from November 2010 to April 2011. Ron also served on President Obama’s Management Advisory Board and currently serves as the Chairman and CEO of RW2 Enterprises and on the board of Boeing and American Express.
SoftBank’s SB Opportunity Fund is a $100 million venture fund. SoftBank Group Corp. is a Japanese multinational conglomerate holding company headquartered in Minato, Tokyo. The Group primarily invests in companies operating in the technology, energy, and financial sectors.
Chairman of Three Seasons Capital, LLC
He was an initial investor in Snyder Communications (NYSE) and a board member until its sale to Havas for $2.3 billion in 1999. He was co-owner and Vice Chairman of The Washington Redskins football team from 1999 to 2004. Mr. Drasner was the founder of the Vehicle Production Group in 2007 and served as its chairman until its sale in 2013.
President, UIA Management
Partner, Ceros Financial Services
Chief Development Officer, Johnson and Johnson Medical Devices Companies
Managing Partner, VH Properties and Director, Virgin Hotels
